D2 vs D3 Lymph Node Dissection for Left Colon Cancer

  • STATUS
    Recruiting
  • End date
    Dec 31, 2028
  • participants needed
    1381
  • sponsor
    Russian Society of Colorectal Surgeons
Updated on 6 October 2021
adenocarcinoma

Summary

The efficiency of the D3 lymph node dissection is still controversial for left colon cancer patients. This study will try find difference in 5-year overall survival between D2 and D3 lymph node dissection. Investigation of the functional and short-term outcomes will clarify safety of the D3 lymph node dissection.

Description

Discussion about optimal type of lymph node dissection in colorectal cancer continues during last 15 years, when in Europe was presented concept of complete mesocolic excision. However, this concepts is very close to Japanese D3 lymph node dissection and in the first view it seems the same but principal differences were found. Japanese concept is partial resection of the bowel according feeding artery (short bowel specimen, long lymphovascular pedicle), opposite European concept is wide resection of the bowel like hemicolectomy or extended hemicolectomy, sigmoidectomy. In complete mesocolic excision anatomical landmarks are still unclear but in Japanese guidelines it has anatomical margins which can standardize this procedure. Also nerve sparing technique around root of inferior mesenteric artery was described. One more difference is in histological examination of the specimen. European concept is to pay more attention to the quality of complete mesocolic excision and less - to the number of investigated lymph nodes. In Japan lymph node extraction is performed by surgical team from the fresh specimen and send to pathologist separately (each group of lymph nodes). Considering the absence of randomized control trials for patients with left colon cancer DILEMMA trial was started using Japanese approach

Details
Condition Colon cancer; rectal cancer, Malignant neoplasm of colon, colon carcinoma, Colorectal Cancer, Colon Cancer, Colon Cancer Screening
Treatment Left colon resection, Sigmoid colon resection, Distal sigmoid colon resection or anterior resection
Clinical Study IdentifierNCT04364373
SponsorRussian Society of Colorectal Surgeons
Last Modified on6 October 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Agreement of the patient to participate in trial
Colon cancer (only adenocarcinoma )
The tumor located between the splenic flexure and rectosigmoid junction
cT3-4,b
cN0-2
cM0
Tolerance of chemotherapy
ASA 1-3

Exclusion Criteria

is - 2, 4b (tail of the pancreas, stomach, small bowel, ureter, urinary bladder)
Preoperative complications of the tumor (perforation and full bowel 3. obstruction)
Previous radiotherapy or chemotherapy
Synchronous or metachronous tumors
Women during Pregnancy or breast feeding period
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note